Neuroplasticity, Psychedelics, and Mental Health
February 17, 2022
Robin Lefferts February 17th, 2022 Psychedelics, Top News The brain is a tangled, incredibly complex mass of about 86 billion neurons. The ability to create new neurons, called neurogenesis, was long thought to stop by the age of 25. There is some debate, however, as one recent study put... Read more
NeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontario
February 17, 2022
Ryan Allway February 17th, 2022 News, Top News Mississauga facility expected to begin treatment services in the Second Half of 2022 First location selected as part of a nationwide buildout of NeonMind-branded clinics offering interventional psychiatry treatments Vancouver, B.C. – February 17, 2022: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF)... Read more
TILT Enters into Multi-State Agreement to Manufacture and Distribute Cannabis Brand Toast™
Massachusetts February 17, 2022
Ryan Allway February 17th, 2022 News, Top News PHOENIX, February 17, 2022 (Globe Newswire) — Tilt Holdings Inc. (“Tilt” or “Company”) (NEO: dance) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technology, cultivation, manufacturing, processing, brand development and retail, today announced a multi-state licensing agreement. Toast™An Aspen, Colorado-born national cannabis... Read more
Khiron Adds Another Clinic Location in Peru
February 17, 2022
This addition collectively brings the Company’s total clinic count to 16 globally, which includes presence in Colombia, Peru and the United Kingdom Peru represented 5% of the total Latin America unit sales in 2021 In the second half of 2021, the Company opened its first Zerenia™ clinic in Lima, in partnership with Clínica Montesur. Since opening the... Read more
Zollaris Laboratories Corp. Receives Health Canada authorization to investigate PSILOCYBIN (PSYCHEDELIC MUSHROOMS) for potential new therapeutics
February 16, 2022
Ryan Allway February 16th, 2022 Psychedelics, Top News Psilocybin therapy is being investigated by Zollaris for the treatment of mental health and other unmet medical needs HAWKESBURY PROVIDENCE, Ontario, Feb. 16, 2022 /PRNewswire-PRWeb/ — Zollaris Laboratories Corporation. (hereafter, “Zollaris”) receives authorization from the Health Canada, Office of Controlled Substances for analytical investigation of several... Read more
South America’s most advanced Cannabis Extraction Equipment to be installed outside Bogota, Colombia.
February 16, 2022
Ryan Allway February 16th, 2022 News, Top News BOGOTA, Feb 16, 2022 /PRNewswire/ — CannabCo Pharmaceutical Corp. Colombia S.A.S. (CannabCo Colombia), a Colombia-based cannabis cultivator and manufacturer of medical cannabis products, is pleased to announce the procurement of an enhanced integrated extraction platform to be deployed in their Colombian extraction... Read more
Ryan Allway February 16th, 2022 News, Top News CALGARY, AB, Feb. 16, 2022 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to provide an update on its recent Canadian recreational market share. “Our market share growth continues to gain momentum,... Read more
Initiation of Phase 1 clinical trial of SBI-100 ophthalmic nanemulsion expected in second the quarter of 2022 SAN DIEGO, CA, February 16, 2022 (GLOBE NEWSWIRE) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced that... Read more
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
February 16, 2022
VANCOUVER, BC (GLOBE NEWSWIRE – February 16, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report that Health Canada has added the... Read more
Canonic Announces Professor Itamar Grotto Joining its Board of Directors
February 16, 2022
Ryan Allway February 16th, 2022 News, Top News Professor Grotto is a world-renowned expert in public health; As former Associate Director General at the Israeli Ministry of Health he led the medicalization reform of cannabis in Israel Rehovot, Israel – February 16, 2022 – Canonic Ltd., focused on the development of... Read more
